PMA device
Thoraflex Hybrid
Vascutek, Ltd. · Hybrid Stent Graft, Thoracic Aortic Lesion Treatment (QSK, Class III) · First FDA decision Apr 19, 2022, newest Sep 8, 2026Aortic aneurysm and dissection
Last checked: Nov 20, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
5
Breakthrough-designated
Device trials
6
Naming "Thoraflex"
MAUDE reports
197
Brand "Thoraflex", since 2015
PubMed studies
111
Mentioning "Thoraflex"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing Thoraflex Hybrid
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology, with pictures of the device
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 5 of 5 decisions filed under this name.
- Thoraflex HybridPMA supplement
P210006-S018 · Decided Sep 8, 2026 · 180 days after receipt · Normal 180 Day Track
Device type: Hybrid stent graft, thoracic aortic lesion treatment (QSK) · Cardiology
4 more FDA decisions with a free account
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
- Venous Angioplasty with or without Stent Placement for the Treatment of Chronic Cerebrospinal Venous InsufficiencyLocal determinationIn effectL35028Wellpoint FederalUpdated Jul 14, 2026
- MolDX: Genetic Testing for Heritable Thoracic Aortic DiseaseLocal determinationIn effectL39938CGS Administrators, LLCUpdated Jun 19, 2026
- MolDX: Genetic Testing for Heritable Thoracic Aortic DiseaseLocal determinationIn effectL39944Noridian Healthcare Solutions, LLCUpdated Jan 12, 2026
- MolDX: Genetic Testing for Heritable Thoracic Aortic DiseaseLocal determinationIn effectL39989WPS Insurance CorporationUpdated Jun 25, 2025
- MolDX: Genetic Testing for Heritable Thoracic Aortic DiseaseLocal determinationIn effectL39933Palmetto GBAUpdated Jun 25, 2025
- Application of Skin Substitute Grafts for Treatment of DFU and VLU of Lower ExtremitiesLocal determinationIn effectL36377First Coast Service Options, Inc.Updated Nov 21, 2019
Clinical trials
Device studies on ClinicalTrials.gov that name "Thoraflex", any status and sponsor, newest update first.
- Clinical Health Outcomes Evaluation of Terumo Aortic Hybrid DevicesNot yet recruiting
Vascutek Ltd.Not on our public-company list
NCT07911163 · 150 participants (planned) · Start May 2027 · Primary completion May 2039
Device: Thoraflex Hybrid · For: Aortic Aneurysm and Dissection
5 more trials with a free account
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "Thoraflex", and for the whole product code for context.
This brand
197 reports: 32 malfunction, 134 injury, 31 death
Whole product code QSK
346 reports: 34 malfunction, 277 injury, 35 death
Newest reports for this brand
- Thoraflex HybridInjury
9612515-2026-00070 · Received Oct 29, 2026 · Event dated Sep 3, 2025
Device type: Hybrid Stent Graft, Thoracic Aortic Lesion Treatment (QSK)
Device problem as coded: Adverse Event Without Identified Device or Use Problem
Patient problem as coded: Stroke/CVA; Obstruction/Occlusion; Vascular Dissection
4 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "Thoraflex"[tiab]. The summary above synthesizes these.
- Thoraflex Hybrid Prosthesis (THP): the profile.
Jubouri M, Kayali F, Agbobu T, et al. · Expert Rev Med Devices · 2024Review
- What Is the Long-Term Clinical Efficacy of the Thoraflexࡊ Hybrid Prosthesis for Aortic Arch Repair?
Tan SZCP, Jubouri M, Mohammed I, et al. · Front Cardiovasc Med · 2022
- Type IIa endoleak in thoraflex hybrid stent-graft for frozen elephant trunk operation.
Luthra S, Tsang GM · Asian Cardiovasc Thorac Ann · 2023
- Total aortic arch replacement with frozen elephant trunk (Thoraflex).
Di Marco L, Pacini D, Murana G, et al. · Ann Cardiothorac Surg · 2018Editorial
- Thoraflex Hybrid vs. AMDS: To replace the arch or to stent it in type A aortic dissection?
Al-Tawil M, Jubouri M, Tan SZ, et al. · Asian Cardiovasc Thorac Ann · 2023Review
- Open descending aortic replacement after Thoraflexࡊ hybrid graft implantation.
Fujikawa T, Ho JYK, Wong HMK, et al. · Eur J Cardiothorac Surg · 2019
- Single-Center Experience With the Thoraflexࡊ Hybrid Prosthesis: Indications, Implantation Technique and Results.
Wisniewski K, Motekallemi A, Dell'Aquila AM, et al. · Front Cardiovasc Med · 2022
- T-NEXT graft: step by step operative technique.
Di Eusanio M, Berretta P, Gatta E · Ann Cardiothorac Surg · 2025Editorial
- Frozen elephant trunk technique using hybrid grafts: 15-year outcomes from a single-centre experience.
Murana G, Gliozzi G, Di Marco L, et al. · Eur J Cardiothorac Surg · 2024
- Concurrent stabilization of "downstream" aorta during acute type A aortic dissection repair.
Luthra S, Tsang GM · J Thorac Cardiovasc Surg · 2023Editorial
- Thoraflex Graft in an Inverted Position for Post-Dissection Thoracoabdominal Aneurysm.
Ravaux JM, Remy P, Detroux M, et al. · Ann Thorac Surg · 2019Case Reports
- Distal Stent Graft-Induced New Entries After the Frozen Elephant Trunk Procedure.
Kreibich M, Bünte D, Berger T, et al. · Ann Thorac Surg · 2020
Other devices of this type
Also filed under product code QSK.
- AMDS Hybrid ProsthesisArtivion, Inc. · PMA 2026
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.